Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
Sell
-100,278
Closed -$2.54M 221
2025
Q1
$2.54M Buy
+100,278
New +$2.62M 0.63% 44
2023
Q2
Sell
-5,418
Closed -$207K 154
2023
Q1
$207K Buy
+5,418
New +$234K 0.08% 102
2022
Q3
Sell
-4,216
Closed -$221K 124
2022
Q2
$221K Sell
4,216
-936
-18% -$47.7K 0.14% 80
2022
Q1
$267K Buy
+5,152
New +$267K 0.09% 100
2021
Q4
Sell
-13,631
Closed -$586K 93
2021
Q3
$586K Sell
13,631
-5,316
-28% -$236K 0.23% 59
2021
Q2
$742K Sell
18,947
-17,651
-48% -$686K 0.49% 43
2021
Q1
$1.33M Buy
+36,598
New +$1.3M 0.45% 35
2020
Q2
Sell
-31,619
Closed -$979K 93
2020
Q1
$979K Buy
+31,619
New +$1.08M 1.02% 22

Other funds holding PFE

Banco BTG Pactual's PFE Position: Q2 2025 in Review

Banco BTG Pactual sold out of Pfizer (PFE) in Q2 2025, closing a stake of 100,278 shares — an estimated $2.54M sold.

Banco BTG Pactual first reported a position in PFE in Q1 2020 and held it in 8 quarters. The position peaked at $2.54M in Q1 2025. 2,809 funds tracked by Wall St. Rank hold PFE as of Q2 2025.

  • Banco BTG Pactual reported no remaining Pfizer position as of Q2 2025 after selling out during the quarter.
  • Banco BTG Pactual sold 100,278 Pfizer shares in Q2 2025, an estimated $2.54M.
  • Banco BTG Pactual first reported a position in Pfizer in Q1 2020 and held it in 8 quarters.
  • Banco BTG Pactual's Pfizer position peaked at $2.54M in Q1 2025.
  • 2,809 funds tracked by Wall St. Rank held Pfizer as of Q2 2025.

Based on Banco BTG Pactual's 13F filing for Q2 2025, filed 14 Aug 2025.